Find and Pitch Jounalists, Get Your Story Covered

Tags: amazon bob chapek crunchyroll disney epic games

	Profile	Recent Articles on Subject
1	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: The end of 23andMe’s drug discovery dream - 6 days ago STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease - 5 months ago
2	Bob Herman STAT News Health care business reporter. Indiana Health carebusiness	STAT+: What a second Trump term means for hospitals, insurers, and Medicare - 6 days ago STAT+: What the Trump administration could mean for the health care industry, from hospitals to pharma - 6 days ago STAT+: Hospitals prepare to sway the Supreme Court on Medicare payments - 13 days ago STAT+: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows - about 1 month ago STAT+: Why health care spending keeps climbing - 5 months ago
3	Theresa Gaffney STAT News Audio producer, health reporter. Boston audio productionhealth reporting	A STAT Investigation: Pain, loss, and coercive care - 6 days ago Morning Rounds: Highlights from the STAT Summit - about 1 month ago STAT Morning Rounds: Six health news stories you need to start your day - 12 months ago
4	Tara Bannow STAT News Reporter @statnews. healthcarejournalism	STAT+: What the Trump administration could mean for the health care industry, from hospitals to pharma - 6 days ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 9 days ago STAT+: Up and down the ladder: The latest comings and goings - 16 days ago STAT+: Up and down the ladder: The latest comings and goings - 23 days ago STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more - 27 days ago STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 10 months ago STAT+: Up and down the ladder: The latest comings and goings - 10 months ago STAT+: Up and down the ladder: The latest comings and goings - 10 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and Down the Ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago
6	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Trump’s return raises concerns about funding cuts and politicization at the NIH - 9 days ago STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present - 2 months ago
7	Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. health carebusiness reporting	Morning Rounds: A STAT crossword, Atul Gawande, and hearing music with hearing aids - about 1 month ago STAT+: 3 health policies states are taking on in 2024 - 11 months ago
8	Casey Ross STAT News National health tech writer @statnews. Covers #AI, #digitalhealth. Cleveland, OH health technologyjournalismartificial intelligencedigital health	STAT+: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows - about 1 month ago STAT Virtual Event: Putting AI to the Test - about 1 year ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more - 2 months ago STAT+: A scientific mystery highlights the blind spots in genomics databases - 8 months ago STAT+: A Q&A with the global head of Boehringer Ingelheim’s innovation unit - about 1 year ago
10	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Tome Biosciences files notice to lay off virtually entire staff - 3 months ago STAT+: Tome Biosciences, once a high-flying gene-editing startup, is floundering - 3 months ago

Journalists covering STAT News